AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mirum Pharmaceuticals, Inc. Director's Dealing 2021

Mar 9, 2021

31228_dirs_2021-03-08_30c5a2d1-7766-4ae0-ae7a-79201ee26967.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2020-12-23

Reporting Person: Clements Ian (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-23	Common Stock	P	1592	$18.65	Acquired	7871	Direct

Footnotes

F1: This Form 4 is being amended to correct the number of shares purchased and the amount of securities beneficially owned following the reported transaction.